See more : Enplas Corporation (6961.T) Income Statement Analysis – Financial Results
Complete financial analysis of Unrivaled Brands, Inc. (UNRV) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Unrivaled Brands, Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- The Walt Disney Company (DIS.NE) Income Statement Analysis – Financial Results
- CHW Acquisition Corporation (CHWAU) Income Statement Analysis – Financial Results
- Hana Microelectronics Public Company Limited (HANA-R.BK) Income Statement Analysis – Financial Results
- Biofrontera AG (B8F.DE) Income Statement Analysis – Financial Results
- Stryker Corporation (0R2S.L) Income Statement Analysis – Financial Results
Unrivaled Brands, Inc. (UNRV)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.unrivaledbrands.com
About Unrivaled Brands, Inc.
Unrivaled Brands, Inc. cultivates, produces, distributes, and retails medical and adult use cannabis products in California, Oregon, and Nevada. It also operates medical marijuana retail and adult use dispensaries, cultivation, and production facilities. The company was formerly known as Terra Tech Corp. and changed its name to Unrivaled Brands, Inc. in July 2021. Unrivaled Brands, Inc. was founded in 2010 and is based in Santa Ana, California.
Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 52.02M | 47.67M | 14.29M | 28.05M | 31.33M | 35.80M | 25.33M | 9.98M | 7.09M | 2.13M | 552.58K | 0.00 | 0.00 | 0.00 |
Cost of Revenue | 35.12M | 35.71M | 10.69M | 13.40M | 18.90M | 30.32M | 22.76M | 8.96M | 6.94M | 2.04M | 451.71K | 0.00 | 0.00 | 0.00 |
Gross Profit | 16.90M | 11.97M | 3.60M | 14.65M | 12.43M | 5.48M | 2.57M | 1.02M | 152.99K | 88.92K | 100.87K | 0.00 | 0.00 | 0.00 |
Gross Profit Ratio | 32.48% | 25.10% | 25.20% | 52.24% | 39.68% | 15.30% | 10.16% | 10.19% | 2.16% | 4.18% | 18.25% | 0.00% | 0.00% | 0.00% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 52.04M | 46.99M | 24.41M | 43.83M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 28.99K | 16.44K | 17.33K |
Selling & Marketing | 2.12M | 1.27M | 190.00K | 1.49M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 54.16M | 48.26M | 24.60M | 45.32M | 43.30M | 25.36M | 20.72M | 9.83M | 18.33M | 3.58M | 1.07M | 28.99K | 16.44K | 17.33K |
Other Expenses | 156.50M | -433.00K | 964.00K | 144.00K | 0.00 | 565.52K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating Expenses | 210.66M | 48.26M | 24.60M | 45.32M | 43.30M | 25.36M | 20.72M | 9.83M | 18.33M | 3.58M | 1.07M | 28.99K | 16.44K | 17.33K |
Cost & Expenses | 245.78M | 83.96M | 35.29M | 58.72M | 62.20M | 55.68M | 43.48M | 18.79M | 25.27M | 5.61M | 1.52M | 28.99K | 16.44K | 17.33K |
Interest Income | 4.17M | 1.78M | 1.39M | 9.29M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 4.17M | 1.78M | 2.93M | 9.30M | 13.09M | 2.68M | 1.79M | 1.17M | 1.10M | 1.28M | 62.20K | 0.00 | 0.00 | 0.00 |
Depreciation & Amortization | 13.40M | 8.96M | 964.00K | 6.29M | 4.98M | 3.65M | 2.54M | 645.29K | 438.78K | 41.31K | 14.09K | 0.00 | 0.00 | 0.00 |
EBITDA | -193.76M | -29.15M | -12.76M | -39.29M | -24.48M | -16.23M | -18.15M | -8.17M | -17.74M | -3.45M | -957.91K | -28.99K | -16.44K | -17.33K |
EBITDA Ratio | -372.51% | -57.33% | -140.25% | -86.91% | -84.74% | -45.34% | -71.65% | -81.92% | -250.00% | -162.08% | -173.35% | 0.00% | 0.00% | 0.00% |
Operating Income | -193.76M | -36.29M | -21.00M | -30.67M | -30.87M | -19.88M | -18.15M | -8.82M | -18.17M | -3.49M | -5.77M | -28.99K | -16.44K | -17.33K |
Operating Income Ratio | -372.51% | -76.12% | -147.00% | -109.33% | -98.52% | -55.53% | -71.65% | -88.39% | -256.19% | -164.03% | -1,044.55% | 0.00% | 0.00% | 0.00% |
Total Other Income/Expenses | -1.87M | -5.89M | -9.12M | -17.77M | -8.60M | -13.65M | -9.84M | -546.10K | -3.99M | -2.66M | -63.53K | 0.00 | 0.00 | 0.00 |
Income Before Tax | -195.63M | -42.18M | -13.80M | -48.44M | -39.47M | -33.53M | -27.99M | -9.36M | -22.17M | -6.15M | -5.84M | -28.99K | -16.44K | -17.33K |
Income Before Tax Ratio | -376.11% | -88.47% | -96.59% | -172.70% | -125.98% | -93.66% | -110.49% | -93.86% | -312.46% | -289.14% | -1,056.05% | 0.00% | 0.00% | 0.00% |
Income Tax Expense | -2.78M | 885.00K | 13.04M | 6.87M | 279.61K | -347.46K | -1.07M | 44.00K | 13.46K | 1.65K | 879.00 | 28.99K | 16.44K | 17.33K |
Net Income | -192.85M | -43.06M | -26.84M | -55.31M | -39.75M | -32.68M | -26.92M | -9.23M | -21.89M | -6.15M | -5.84M | -28.99K | -16.44K | -17.33K |
Net Income Ratio | -370.76% | -90.33% | -187.88% | -197.17% | -126.87% | -91.28% | -106.28% | -92.48% | -308.55% | -289.22% | -1,056.21% | 0.00% | 0.00% | 0.00% |
EPS | -0.33 | -0.11 | -0.14 | -0.52 | -0.56 | -0.71 | -0.93 | -0.52 | -1.88 | -0.93 | -1.14 | 0.00 | 0.00 | 0.00 |
EPS Diluted | -0.33 | -0.11 | -0.14 | -0.52 | -0.56 | -0.71 | -0.93 | -0.52 | -1.88 | -0.93 | -1.14 | 0.00 | 0.00 | 0.00 |
Weighted Avg Shares Out | 589.55M | 376.63M | 191.98M | 106.04M | 71.03M | 46.07M | 28.84M | 17.79M | 11.62M | 6.60M | 5.13M | 79.69M | 100.18M | 100.00M |
Weighted Avg Shares Out (Dil) | 589.55M | 376.63M | 191.98M | 106.04M | 71.03M | 46.07M | 28.84M | 17.79M | 11.62M | 6.60M | 5.13M | 79.69M | 100.18M | 100.00M |
Blüm Holdings Reports Encouraging Preliminary 2023 Revenues Amidst Comprehensive Corporate Overhaul and Market Challenges
Blüm Holdings Refocuses on Cannabis Retail and Brand Leadership with Strategic Sale of Cultivation Assets
Blum Holdings, Announces Future Trading as BLMH; Currently Trades as UNRVD Following Reorganization and Reverse Stock Split
Unrivaled Brands Announces Successful Completion of Reorganization and Reverse Stock Split
Unrivaled Brands Reports Average 96% Consolidated Stockholder Voting Support
Unrivaled Brands Announces Non-Binding Letters of Intent For a Significant Acquisition and Provides Stockholder Update
Unrivaled Brands Announces Settlement of Litigation and Debt
Unrivaled Brands Reports Third Quarter 2023 Financial Results
Unrivaled Brands Ranked Among Most Improved “Credit Quality” of Cannabis Peers
Unrivaled Brands Files S-4; Announces Corporate Reorganization to become Blüm
Source: https://incomestatements.info
Category: Stock Reports